aluates Reports

$ 0.0

Automative

Global Trivalent Flu Vaccine Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-33Q592

Global Trivalent Flu Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Trivalent Flu Vaccine Market Research Report 2024

Code: QYRE-Auto-33Q592

Report

January 2024

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Serum Institute of India

Trivalent Flu Vaccine Market Size

The global Trivalent Flu Vaccine market was valued at US$ 220.2 million in 2023 and is anticipated to reach US$ 304.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Trivalent Flu Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Trivalent Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trivalent Flu Vaccine.

Report Scope

The Trivalent Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Trivalent Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Trivalent Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Trivalent Flu Vaccine Market Report

Report Metric	Details
Report Name	Trivalent Flu Vaccine Market
Accounted market size in 2023	US$ 220.2 million
Forecasted market size in 2030	US$ 304.3 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Intramuscular Injection Nasal Spray Intradermal Shot
Segment by Application	Hospital Clinic Public Health Agency Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute of India
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Trivalent Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Trivalent Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Trivalent Flu Vaccine Market growing?

Ans: The Trivalent Flu Vaccine Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Trivalent Flu Vaccine Market size in 2030?

Ans: The Trivalent Flu Vaccine Market size in 2030 will be US$ 304.3 million.

Who are the main players in the Trivalent Flu Vaccine Market report?

Ans: The main players in the Trivalent Flu Vaccine Market are Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute of India

What are the Application segmentation covered in the Trivalent Flu Vaccine Market report?

Ans: The Applications covered in the Trivalent Flu Vaccine Market report are Hospital, Clinic, Public Health Agency, Other

What are the Type segmentation covered in the Trivalent Flu Vaccine Market report?

Ans: The Types covered in the Trivalent Flu Vaccine Market report are Intramuscular Injection, Nasal Spray, Intradermal Shot

1 Trivalent Flu Vaccine Market Overview

1.1 Product Overview and Scope of Trivalent Flu Vaccine

1.2 Trivalent Flu Vaccine Segment by Type

1.2.1 Global Trivalent Flu Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Intramuscular Injection

1.2.3 Nasal Spray

1.2.4 Intradermal Shot

1.3 Trivalent Flu Vaccine Segment by Application

1.3.1 Global Trivalent Flu Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Public Health Agency

1.3.5 Other

1.4 Global Trivalent Flu Vaccine Market Size Estimates and Forecasts

1.4.1 Global Trivalent Flu Vaccine Revenue 2019-2030

1.4.2 Global Trivalent Flu Vaccine Sales 2019-2030

1.4.3 Global Trivalent Flu Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Trivalent Flu Vaccine Market Competition by Manufacturers

2.1 Global Trivalent Flu Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Trivalent Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Trivalent Flu Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Trivalent Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Trivalent Flu Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Trivalent Flu Vaccine, Product Type & Application

2.7 Trivalent Flu Vaccine Market Competitive Situation and Trends

2.7.1 Trivalent Flu Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Trivalent Flu Vaccine Players Market Share by Revenue

2.7.3 Global Trivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Trivalent Flu Vaccine Retrospective Market Scenario by Region

3.1 Global Trivalent Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Trivalent Flu Vaccine Global Trivalent Flu Vaccine Sales by Region: 2019-2030

3.2.1 Global Trivalent Flu Vaccine Sales by Region: 2019-2024

3.2.2 Global Trivalent Flu Vaccine Sales by Region: 2025-2030

3.3 Global Trivalent Flu Vaccine Global Trivalent Flu Vaccine Revenue by Region: 2019-2030

3.3.1 Global Trivalent Flu Vaccine Revenue by Region: 2019-2024

3.3.2 Global Trivalent Flu Vaccine Revenue by Region: 2025-2030

3.4 North America Trivalent Flu Vaccine Market Facts & Figures by Country

3.4.1 North America Trivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Trivalent Flu Vaccine Sales by Country (2019-2030)

3.4.3 North America Trivalent Flu Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Trivalent Flu Vaccine Market Facts & Figures by Country

3.5.1 Europe Trivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Trivalent Flu Vaccine Sales by Country (2019-2030)

3.5.3 Europe Trivalent Flu Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Trivalent Flu Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Trivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Trivalent Flu Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Trivalent Flu Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Trivalent Flu Vaccine Market Facts & Figures by Country

3.7.1 Latin America Trivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Trivalent Flu Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Trivalent Flu Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Trivalent Flu Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Trivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Trivalent Flu Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Trivalent Flu Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Trivalent Flu Vaccine Sales by Type (2019-2030)

4.1.1 Global Trivalent Flu Vaccine Sales by Type (2019-2024)

4.1.2 Global Trivalent Flu Vaccine Sales by Type (2025-2030)

4.1.3 Global Trivalent Flu Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Trivalent Flu Vaccine Revenue by Type (2019-2030)

4.2.1 Global Trivalent Flu Vaccine Revenue by Type (2019-2024)

4.2.2 Global Trivalent Flu Vaccine Revenue by Type (2025-2030)

4.2.3 Global Trivalent Flu Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Trivalent Flu Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Trivalent Flu Vaccine Sales by Application (2019-2030)

5.1.1 Global Trivalent Flu Vaccine Sales by Application (2019-2024)

5.1.2 Global Trivalent Flu Vaccine Sales by Application (2025-2030)

5.1.3 Global Trivalent Flu Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Trivalent Flu Vaccine Revenue by Application (2019-2030)

5.2.1 Global Trivalent Flu Vaccine Revenue by Application (2019-2024)

5.2.2 Global Trivalent Flu Vaccine Revenue by Application (2025-2030)

5.2.3 Global Trivalent Flu Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Trivalent Flu Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Pasteur Trivalent Flu Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Trivalent Flu Vaccine Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 CSL

6.3.1 CSL Corporation Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 CSL Trivalent Flu Vaccine Product Portfolio

6.3.5 CSL Recent Developments/Updates

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Description and Business Overview

6.4.3 Abbott Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Abbott Trivalent Flu Vaccine Product Portfolio

6.4.5 Abbott Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Trivalent Flu Vaccine Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Serum Institute of India

6.6.1 Serum Institute of India Corporation Information

6.6.2 Serum Institute of India Description and Business Overview

6.6.3 Serum Institute of India Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Serum Institute of India Trivalent Flu Vaccine Product Portfolio

6.6.5 Serum Institute of India Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Trivalent Flu Vaccine Industry Chain Analysis

7.2 Trivalent Flu Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Trivalent Flu Vaccine Production Mode & Process

7.4 Trivalent Flu Vaccine Sales and Marketing

7.4.1 Trivalent Flu Vaccine Sales Channels

7.4.2 Trivalent Flu Vaccine Distributors

7.5 Trivalent Flu Vaccine Customers

8 Trivalent Flu Vaccine Market Dynamics

8.1 Trivalent Flu Vaccine Industry Trends

8.2 Trivalent Flu Vaccine Market Drivers

8.3 Trivalent Flu Vaccine Market Challenges

8.4 Trivalent Flu Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Serum Institute of India

List of Tables

Table 1. Global Trivalent Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Trivalent Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Trivalent Flu Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Trivalent Flu Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Trivalent Flu Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Trivalent Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Trivalent Flu Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Trivalent Flu Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Trivalent Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Trivalent Flu Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Trivalent Flu Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Trivalent Flu Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Trivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trivalent Flu Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Trivalent Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Trivalent Flu Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Trivalent Flu Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Trivalent Flu Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Trivalent Flu Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Trivalent Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Trivalent Flu Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Trivalent Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Trivalent Flu Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Trivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Trivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Trivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Trivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Trivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Trivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Trivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Trivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Trivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Trivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Trivalent Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Trivalent Flu Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Trivalent Flu Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Trivalent Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Trivalent Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Trivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Trivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Trivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Trivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Trivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Trivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Trivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Trivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Trivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Trivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Trivalent Flu Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Trivalent Flu Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Trivalent Flu Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Trivalent Flu Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Trivalent Flu Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Trivalent Flu Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Trivalent Flu Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Trivalent Flu Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Trivalent Flu Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Trivalent Flu Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Trivalent Flu Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Trivalent Flu Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Trivalent Flu Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Trivalent Flu Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Trivalent Flu Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Trivalent Flu Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Trivalent Flu Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Trivalent Flu Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Trivalent Flu Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Trivalent Flu Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. Sanofi Pasteur Corporation Information

Table 71. Sanofi Pasteur Description and Business Overview

Table 72. Sanofi Pasteur Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Sanofi Pasteur Trivalent Flu Vaccine Product

Table 74. Sanofi Pasteur Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. AstraZeneca Trivalent Flu Vaccine Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. CSL Corporation Information

Table 81. CSL Description and Business Overview

Table 82. CSL Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. CSL Trivalent Flu Vaccine Product

Table 84. CSL Recent Developments/Updates

Table 85. Abbott Corporation Information

Table 86. Abbott Description and Business Overview

Table 87. Abbott Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Abbott Trivalent Flu Vaccine Product

Table 89. Abbott Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Trivalent Flu Vaccine Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Serum Institute of India Corporation Information

Table 96. Serum Institute of India Description and Business Overview

Table 97. Serum Institute of India Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Serum Institute of India Trivalent Flu Vaccine Product

Table 99. Serum Institute of India Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Trivalent Flu Vaccine Distributors List

Table 103. Trivalent Flu Vaccine Customers List

Table 104. Trivalent Flu Vaccine Market Trends

Table 105. Trivalent Flu Vaccine Market Drivers

Table 106. Trivalent Flu Vaccine Market Challenges

Table 107. Trivalent Flu Vaccine Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Trivalent Flu Vaccine

Figure 2. Global Trivalent Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Trivalent Flu Vaccine Market Share by Type in 2023 & 2030

Figure 4. Intramuscular Injection Product Picture

Figure 5. Nasal Spray Product Picture

Figure 6. Intradermal Shot Product Picture

Figure 7. Global Trivalent Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Trivalent Flu Vaccine Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Public Health Agency

Figure 12. Other

Figure 13. Global Trivalent Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Trivalent Flu Vaccine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Trivalent Flu Vaccine Sales (2019-2030) & (K Doses)

Figure 16. Global Trivalent Flu Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 17. Trivalent Flu Vaccine Report Years Considered

Figure 18. Trivalent Flu Vaccine Sales Share by Manufacturers in 2023

Figure 19. Global Trivalent Flu Vaccine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Trivalent Flu Vaccine Players: Market Share by Revenue in 2023

Figure 21. Trivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Trivalent Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Trivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 24. North America Trivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Trivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 28. Europe Trivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Trivalent Flu Vaccine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Trivalent Flu Vaccine Revenue Market Share by Region (2019-2030)

Figure 36. China Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Trivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 47. Latin America Trivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Trivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Trivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Trivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Trivalent Flu Vaccine by Type (2019-2030)

Figure 57. Global Revenue Market Share of Trivalent Flu Vaccine by Type (2019-2030)

Figure 58. Global Trivalent Flu Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 59. Global Sales Market Share of Trivalent Flu Vaccine by Application (2019-2030)

Figure 60. Global Revenue Market Share of Trivalent Flu Vaccine by Application (2019-2030)

Figure 61. Global Trivalent Flu Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 62. Trivalent Flu Vaccine Value Chain

Figure 63. Trivalent Flu Vaccine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions